Zobrazeno 1 - 10
of 163
pro vyhledávání: '"MARC B. GARNICK"'
Autor:
Marc B Garnick
Publikováno v:
Revista Brasileira de Cancerologia, Vol 33, Iss 4 (2023)
Major advances have taken place in the overall management of patients with ali forms of testicular cancer The current articie reviews the approach to diagnosis, staging, and treatment of patients with both seminomatous and nonseminomatous germ celi c
Externí odkaz:
https://doaj.org/article/31b5eafe6036462992639c1c7e9c18e5
Autor:
E. David Crawford, David M. Albala, Richard G. Harris, Susan F. Slovin, Alan H. Bryce, Peter R. Carroll, Steven E. Finkelstein, Marc B. Garnick, Leonard G. Gomella, Celestia S. Higano, Sonya J. Koo, Daniel P. Petrylak, Scott B. Sellinger, Evan Y. Yu, Rana R. McKay, Mike 'Bing' Crosby, Matthew R. Cooperberg, Phillip J. Koo
Publikováno v:
JU Open Plus. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c444c02f85f69ce7e9e1114ac7d55a1d
https://doi.org/10.1097/ju9.0000000000000003
https://doi.org/10.1097/ju9.0000000000000003
Autor:
Marc B. Garnick, Andrew A. Wagner
Publikováno v:
Urology. 165
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::400b3236f941cb227ea4e5dda4715a83
https://pubmed.ncbi.nlm.nih.gov/35843695
https://pubmed.ncbi.nlm.nih.gov/35843695
Autor:
Fred Saad, Daniel J. George, Michael Cookson, Daniel Saltzstein, Ronald F. Tutrone, Marc B. Garnick, Bruce Brown, Sophia Lu, Mark Fallick, Sarah Hanson, E. David Crawford, Neal D. Shore
Publikováno v:
Journal of Clinical Oncology. 40:5073-5073
5073 Background: BMI has been correlated with adverse prostate cancer outcomes, such as risk of biochemical failure, mortality and androgen deprivation therapy complications. Relugolix is a FDA-approved, once-daily oral GnRH receptor antagonist that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d58f3077ab84a7c48911c7035fba86d2
https://doi.org/10.1200/jco.2022.40.16_suppl.5073
https://doi.org/10.1200/jco.2022.40.16_suppl.5073
Autor:
Marc B Garnick, Aria Olumi
Publikováno v:
Urology. 155
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25e403677964caea5842b81815cc46b0
https://pubmed.ncbi.nlm.nih.gov/34489004
https://pubmed.ncbi.nlm.nih.gov/34489004
Autor:
Robert Pilarski, Arthur L. Burnett, Lucia R. Languino, Colette Hyatt, Jacqueline Powers, Robert B. Den, Alberto Briganti, Veda N. Giri, Lorelei A. Mucci, Daniel P. Petrylak, Oliver Sartor, Amie Blanco, Daniel W. Lin, Himisha Beltran, E. David Crawford, Karen E. Knudsen, Mary-Ellen Taplin, Brian T. Helfand, Felix Y. Feng, Costas D. Lallas, E. Michael D. Scott, Wayne H. Pinover, R. Jeffrey Karnes, Scott Weissman, Evan Y. Yu, Timothy R. Rebbeck, Ashley H. Woodson, Matthew J. Schiewer, Todd M. Morgan, William B. Isaacs, Jeffrey N. Weitzel, Alanna Kulchak Rahm, Michael S. Cookson, James A. Eastham, S. Bruce Malkowicz, Neha Vapiwala, Kevin R. Loughlin, Raoul S. Concepcion, Ana Maria Lopez, Jose Moreno, Brock O'Neil, Patrick T. Gomella, Patrick Mille, Charnita Zeigler-Johnson, Howard M. Sandler, Kathleen A. Cooney, William Tester, Sarah M. Nielsen, Thomas J. Polascik, Richard C. Wender, Howard R. Soule, Ronald E. Myers, Scott E. Eggener, Marc B. Garnick, Stacy Loeb, Martin Miner, Anthony J. Costello, Gerald L. Andriole, Amanda E. Toland, David Y.T. Chen, Albert Dobi, Joseph K Izes, Mary B. Daly, Leonard G. Gomella, Mark D. Hurwitz, J. Kellogg Parsons, Matthew L. Freedman, Nathan Handley, Adam P. Dicker, Jianfeng Xu, Michael Russell Mullane, Charles J. Ryan, Edouard J. Trabulsi, Anne Calvaresi, James Ryan Mark, Thenappan Chandrasekar, Colin C. Pritchard, Saud H. AlDubayan, Curtis A. Pettaway, William Kevin Kelly, Lindsey Byrne, Peter R. Carroll, Brittany M. Szymaniak, Alicia K. Morgans, Peter A. Pinto, William L. Dahut, Mark Mann, Ganesh V. Raj, James L. Mohler, Wendy Poage, Heather H. Cheng, Grace L. Lu-Yao
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 38, iss 24
PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1a0090e4e87cd120ef0899e6263c77c
https://escholarship.org/uc/item/3mg229rb
https://escholarship.org/uc/item/3mg229rb
Autor:
Marc B. Garnick, David J. Einstein
Publikováno v:
Urology
OBJECTIVE: To investigate the adoption of abiraterone and enzalutamide by urologists. Abiraterone and enzalutamide are oral therapies approved for the treatment of metastatic castration-resistant prostate cancer, a disease most commonly treated by me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b484184908cca144e8c15dc2aa928c6
https://pubmed.ncbi.nlm.nih.gov/31136769
https://pubmed.ncbi.nlm.nih.gov/31136769
Autor:
David N. Dahdal, Neal D. Shore, Jehonathan H. Pinthus, Marc B. Garnick, Ferenc G. Rick, Thomas E. Keane, Thomas J.R. Beveridge, Andrew V. Schally, Norman L. Block, Robert H. Eckel, Dennis C Marshall, E. David Crawford
Publikováno v:
Urologic Oncology: Seminars and Original Investigations.
Purpose To explore how follicle-stimulating hormone (FSH) may contribute to cardiovascular, metabolic, skeletal, and cognitive events in men treated for prostate cancer, with various forms of androgen deprivation therapy (ADT). Materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab588ddef1ad36488d6543d4da3df2f
Autor:
Gerald L. Andriole, Marc B. Garnick, E. David Crawford, Daniel P. Petrylak, Charles L. Bennett
Publikováno v:
BJU International. 112:548-560
To review current prostate-specific antigen (PSA) metrics used in monitoring treatment of advanced prostate cancer, with a specific focus on castration-resistant prostate cancer (CRPC) therapies. Explore what is known about the correlation between PS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a76449b4eaa9dde01dd59685ecc8e9b
https://doi.org/10.1111/bju.12061
https://doi.org/10.1111/bju.12061
Autor:
Marc B. Garnick
Publikováno v:
Scientific American. 306:38-43
The article discusses the debate regarding the benefits of the prostate-specific antigen (PSA) test, which is a routine blood test that is used to screen for prostate cancer. According to the U.S. Preventive Services Task Force, little of no long-ter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f4b6bfbe8c8b87c0f5f6f2f1626fb4
https://doi.org/10.1038/scientificamerican0212-38
https://doi.org/10.1038/scientificamerican0212-38